Portland Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $301K | Hold |
4,961
| – | – | 0.03% | 118 |
|
|
2025
Q4 | $268K | Sell |
4,961
-38
| -0.8% | -$1.83K | 0.03% | 124 |
|
|
2025
Q3 | $225K | Hold |
4,999
| – | – | 0.03% | 138 |
|
|
2025
Q2 | $231K | Buy |
4,999
+8
| +0.2% | +$393 | 0.03% | 130 |
|
|
2025
Q1 | $304K | Sell |
4,991
-428
| -8% | -$24.9K | 0.04% | 109 |
|
|
2024
Q4 | $306K | Buy |
5,419
+365
| +7% | +$20.4K | 0.04% | 110 |
|
|
2024
Q3 | $261K | Hold |
5,054
| – | – | 0.03% | 123 |
|
|
2024
Q2 | $210K | Hold |
5,054
| – | – | 0.03% | 129 |
|
|
2024
Q1 | $274K | Sell |
5,054
-210
| -4% | -$10.7K | 0.04% | 122 |
|
|
2023
Q4 | $270K | Hold |
5,264
| – | – | 0.04% | 112 |
|
|
2023
Q3 | $306K | Hold |
5,264
| – | – | 0.05% | 103 |
|
|
2023
Q2 | $337K | Hold |
5,264
| – | – | 0.06% | 103 |
|
|
2023
Q1 | $365K | Sell |
5,264
-1,114
| -17% | -$78.6K | 0.06% | 102 |
|
|
2022
Q4 | $459K | Hold |
6,378
| – | – | 0.08% | 96 |
|
|
2022
Q3 | $453K | Sell |
6,378
-160
| -2% | -$11.6K | 0.09% | 91 |
|
|
2022
Q2 | $503K | Hold |
6,538
| – | – | 0.1% | 92 |
|
|
2022
Q1 | $477K | Hold |
6,538
| – | – | 0.08% | 99 |
|
|
2021
Q4 | $408K | Hold |
6,538
| – | – | 0.07% | 104 |
|
|
2021
Q3 | $387K | Hold |
6,538
| – | – | 0.07% | 113 |
|
|
2021
Q2 | $437K | Sell |
6,538
-30
| -0.5% | -$1.96K | 0.08% | 103 |
|
|
2021
Q1 | $415K | Buy |
6,568
+30
| +0.5% | +$1.87K | 0.09% | 94 |
|
|
2020
Q4 | $406K | Sell |
6,538
-22
| -0.3% | -$1.35K | 0.1% | 92 |
|
|
2020
Q3 | $396K | Buy |
6,560
+22
| +0.3% | +$1.32K | 0.11% | 75 |
|
|
2020
Q2 | $384K | Hold |
6,538
| – | – | 0.12% | 74 |
|
|
2020
Q1 | $364K | Hold |
6,538
| – | – | 0.14% | 72 |
|
|
2019
Q4 | $420K | Hold |
6,538
| – | – | 0.12% | 78 |
|
|
2019
Q3 | $332K | Sell |
6,538
-320
| -5% | -$15K | 0.11% | 84 |
|
|
2019
Q2 | $311K | Hold |
6,858
| – | – | 0.1% | 85 |
|
|
2019
Q1 | $327K | Hold |
6,858
| – | – | 0.11% | 75 |
|
|
2018
Q4 | $356K | Hold |
6,858
| – | – | 0.14% | 71 |
|
|
2018
Q3 | $426K | Hold |
6,858
| – | – | 0.15% | 71 |
|
|
2018
Q2 | $380K | Hold |
6,858
| – | – | 0.14% | 75 |
|
|
2018
Q1 | $434K | Sell |
6,858
-216
| -3% | -$13.9K | 0.17% | 69 |
|
|
2017
Q4 | $433K | Hold |
7,074
| – | – | 0.16% | 67 |
|
|
2017
Q3 | $451K | Hold |
7,074
| – | – | 0.17% | 69 |
|
|
2017
Q2 | $394K | Sell |
7,074
-220
| -3% | -$12K | 0.16% | 70 |
|
|
2017
Q1 | $397K | Buy |
7,294
+220
| +3% | +$12.1K | 0.17% | 69 |
|
|
2016
Q4 | $413K | Hold |
7,074
| – | – | 0.18% | 67 |
|
|
2016
Q3 | $381K | Hold |
7,074
| – | – | 0.17% | 73 |
|
|
2016
Q2 | $520K | Hold |
7,074
| – | – | 0.24% | 64 |
|
|
2016
Q1 | $452K | Hold |
7,074
| – | – | 0.22% | 67 |
|
|
2015
Q4 | $487K | Buy |
7,074
+210
| +3% | +$13.9K | 0.26% | 65 |
|
|
2015
Q3 | $406K | Hold |
6,864
| – | – | 0.24% | 67 |
|
|
2015
Q2 | $457K | Buy |
6,864
+1,034
| +18% | +$68.1K | 0.24% | 66 |
|
|
2015
Q1 | $376K | Hold |
5,830
| – | – | 0.19% | 74 |
|
|
2014
Q4 | $344K | Hold |
5,830
| – | – | 0.18% | 76 |
|
|
2014
Q3 | $298K | Hold |
5,830
| – | – | 0.15% | 90 |
|
|
2014
Q2 | $283K | Hold |
5,830
| – | – | 0.14% | 96 |
|
|
2014
Q1 | $303K | Buy |
5,830
+216
| +4% | +$11.5K | 0.18% | 81 |
|
|
2013
Q4 | $298K | Hold |
5,614
| – | – | 0.19% | 72 |
|
|
2013
Q3 | $260K | Hold |
5,614
| – | – | 0.18% | 73 |
|
|
2013
Q2 | $251K | Buy |
+5,614
| New | +$244K | 0.18% | 74 |
|
Other funds holding BMY
VCM
VPM
Portland Global Advisors's BMY Position: Q1 2026 in Review
Portland Global Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 4,961 shares worth $301K. The position accounts for 0.03% of the portfolio, ranked #118.
Portland Global Advisors first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $520K in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Portland Global Advisors held 4,961 shares of Bristol-Myers Squibb worth $301K as of Q1 2026.
- Portland Global Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.03% of Portland Global Advisors's portfolio in Q1 2026, its #118 holding.
- Portland Global Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Portland Global Advisors's Bristol-Myers Squibb position peaked at $520K in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Portland Global Advisors's 13F filing for Q1 2026, filed 11 May 2026.